Doc2

1. How did Sanofi develop a product strategy for their new vaccine? What actions did they take?

Upon development they set up the industrial capacity, and prepare the market launch in parallel and not in sequence as the company and its competitors used to do. It is in hope that the vaccine will be ready to supply the market the day after approval.

They created a core group named “Dengue Company” within Sanofi employees dedicated to dengue vaccine development, marketing and production.

2. Considering the 7-stage new product development process, currently at what stage Sanofi is? Explain.

It is under the market testing phase. Because they have finished a working prototype and distribute it at the sample market in Thailand, and is planning for fully launch in some of the countries if the results turned out positive

3. In your opinion, having the facility to be built parallel to vaccine development was a right move? Why or why not?

4. Should Sanofi wait for the results of phase III or start a new vaccine development?

5. How did Sanofi develop a product strategy for their new vaccine? What actions did they take?

Upon development they set up the industrial capacity, and prepare the market launch in parallel and not in sequence as the company and its competitors used to do. It is in hope that the vaccine will be ready to supply the market the day after approval.

They created a core group named “Dengue Company” within Sanofi employees dedicated to dengue vaccine development, marketing and production.

6. Considering the 7-stage new product development process, currently at what stage Sanofi is? Explain.

It is under the market testing phase. Because they have finished a working prototype and distribute it at the sample market in Thailand, and is planning for fully launch in some of the countries if the results turned out positive

7. In your opinion, having the facility to be built parallel to vaccine development was a right move?...